In conclusion, results of this pilot study, although preliminary and requiring to be confirmed by other independent studies with larger cohorts, suggest that the interaction between genetic and epigenetic factors modulate SNAP-25 expression and could contribute to the alterations in synaptic functionality, activity, neuro-plasticity observed in AD. The gene discussed is SNAP25; the disease is Alzheimer disease.